A randomised, double-masked, placebo-controlled trial evaluating the efficacy and safety of teprotumumab for active thyroid eye disease in Japanese patients.
- DOI
- 10.1016/j.lanwpc.2025.101464
- Published
- 2025-01-18
- Container
- Lancet Reg Health West Pac
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.lanwpc.2025.101464,
title = {A randomised, double-masked, placebo-controlled trial evaluating the efficacy and safety of teprotumumab for active thyroid eye disease in Japanese patients.},
author = {Hiromatsu Y and Ishikawa E and Kozaki A and Takahashi Y and Tanabe M and Hayashi K and Imagawa Y and Kaneda K and Mimura M and Dai X and Hayashida T and Akamizu T.},
year = {2025},
journal = {Lancet Reg Health West Pac},
doi = {10.1016/j.lanwpc.2025.101464},
url = {https://doi.org/10.1016/j.lanwpc.2025.101464}
}RIS
TY - JOUR TI - A randomised, double-masked, placebo-controlled trial evaluating the efficacy and safety of teprotumumab for active thyroid eye disease in Japanese patients. AU - Hiromatsu Y AU - Ishikawa E AU - Kozaki A AU - Takahashi Y AU - Tanabe M AU - Hayashi K AU - Imagawa Y AU - Kaneda K AU - Mimura M AU - Dai X AU - Hayashida T AU - Akamizu T. PY - 2025 JO - Lancet Reg Health West Pac DO - 10.1016/j.lanwpc.2025.101464 UR - https://doi.org/10.1016/j.lanwpc.2025.101464 ER -
APA
Y, H., E, I., A, K., Y, T., M, T., K, H., Y, I., K, K., M, M., X, D., T, H., & T., A. (2025). A randomised, double-masked, placebo-controlled trial evaluating the efficacy and safety of teprotumumab for active thyroid eye disease in Japanese patients.. Lancet Reg Health West Pac. https://doi.org/10.1016/j.lanwpc.2025.101464
Source records
- europe-pmc · retrieved 2026-09-26T22:36:15.201Z
- doaj · retrieved 2026-09-26T22:36:15.211Z